Short-Course Rituximab Produces Long-Term Remissions of ANCA Vasculitis - Renal and Urology News PDF Print
Renal and Urology News
... Netherlands presented these late-breaking clinical trial results from the RAVE (Rituximab in ANCA-Associated Vasculitis) trial at the 48th Congress of the European Renal Association-European Dialysis and Transplant Association.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.